Sonoma Biotherapeutics CEO Jeff Bluestone and team will be at #ASGCT2025 to share presentations from our Treg cell therapy program! The team looks forward to connecting with others in this exciting space for gene and cell therapy professionals. Read more here: bit.ly/3RNx1jr

This month, take a moment to check in with yourself, take a deep breath, and slow down. Remember that you do not have to deal with mental health alone – let’s raise awareness, support one another, and make mental health a priority every day. #MentalHealthAwareness #OneSonoma

We are thrilled to have Dr. Rajesh Krishnan join Sonoma Biotherapeutics as Chief Technical Officer. Dr. Krishnan’s impressive 25+ years of industry experience in process development and manufacturing, including cell therapy, will make him an invaluable addition to the team. Welcome!

The Sonoma Biotherapeutics team had a great time at #ASGCT2025! The team, including our CEO Jeff Bluestone, shared oral & poster presentations from our Treg cell therapy program. We enjoyed connecting with everyone on the ground at this premier conference for leaders in cell & gene therapy.

Happy #MemorialDay from all of us at Sonoma Biotherapeutics! Today, we thank those who made the ultimate sacrifice for our country. #OneSonoma

In recognition of #HidradenitisSuppurativa (HS) Awareness week, we’re raising awareness for the HS patient community and this painful & chronic condition. We recognize the importance of being at the forefront of research working to cure and change the lives of HS patients.

Our team is excited to be on the ground at @EULAR, connecting with fellow researchers around the world to build knowledge, share ideas, and push the boundaries of excellence in rheumatology. Read more in our latest press release: bit.ly/43OXq64 #Treg #CellTherapy #RA

Our Chief Scientific Officer, Joe Arron, MD, PhD, spoke on the “Expanding the Reach of Cell Therapies: Shaping the Future of Autoimmune Disease Treatment” panel at the 2025 BIO International Convention yesterday. Grateful to be a part of such an educational & encouraging event!

Today, we recognize Juneteenth—a powerful reminder of freedom, resilience, and the ongoing journey toward justice. At Sonoma Biotherapeutics, we believe that innovation thrives in diversity and that true progress is inclusive. Read more here: bit.ly/4n9ABT8 bit.ly/4lcFGIK

June is #PrideMonth, a time to honor the #LGBTQQIP2SA+ movement and their ongoing legacy of progress and commitment to a more inclusive future. Sonoma is proud to celebrate diversity and promote dignity, safety, and rights for all. #OneSonoma #Pride

Sonoma Biotherapeutics is thrilled that our Vice President of Development Science, Hervé Lebrec, PhD, had the opportunity to present a summary of Phase 1 data of SBT115301, an effector T Cell-modulating biologic for autoimmune diseases, at the #FOCIS2025 Annual Meeting last week.

Today, all of us at Sonoma Biotherapeutics wish everyone a safe and happy #IndependenceDay! We are grateful for the spirit of freedom and determination that fuels our nation as well as the work we do here at SonomaBio. #OneSonoma #4thofJuly #Freedom

July is Disability Awareness Month, commemorating the signing of the Americans with Disabilities Act (ADA) in July 1990. At Sonoma Biotherapeutics, we want to take this time to highlight the contributions of those with disabilities – and reflect on how we can strive for inclusive workplaces.

Congratulations to Toni Hoover, SonomaBio board member who was recognized as a Director of the Year by the Puget Sound Business Journal! This award is a well-deserved recognition of the above and beyond dedication Toni provides to our company, employees, and Sonoma mission.

Happy Summer from @SonomaBio! Our teams had a great time participating in some summer fun at our recent company picnics. Thanks to everyone who came out to enjoy one of our favorite traditions. #OneSonomaBio #CellTherapy #Summer

August is #WellnessMonth, and at Sonoma Biotherapeutics we understand its contribution to a happier and healthier workplace. In the spirit of wellness, our Sonoma Biotherapeutics run-club has enjoyed some beautiful days on the running trails in the #SSF and #Seattle area! #OneSonomaBio

We are excited to announce that Lisa Taylor Ash has joined @SonomaBio as Chief Legal Officer. We look forward to Ms. Ash's strategic insight and expertise as we continue to advance our pipeline and execute milestones this year. Read more here: bit.ly/4mVn3tB

Today, on #WomensEqualityDay, we proudly celebrate the remarkable achievements and leadership of the women at @SonomaBio. Their dedication, innovation, and resilience continue to shape our success and drive meaningful progress everyday.

Members of our #Seattle and #SSF teams had a great time participating in our second annual Sonoma Biotherapeutics Service Day this week. We had volunteers at various local organizations, dedicating their time to meaningful work in our community. Thanks to everyone who participated! #Service

At Sonoma Biotherapeutics, we are committed to fostering a workplace that embraces diversity and champions equity and inclusion. Join us in learning, celebrating, and honoring #HispanicHeritageMonth from September 15 through October 15!